Development of a self-efficacy questionnaire, ‘Insulin Therapy Self-efficacy Scale (ITSS)’, for insulin users in Japanese: The Self-Efficacy-Q study

Junko Nakaue, Miyuki Koizumi, Hiroki Nakajima, Sadanori Okada, Takako Mohri, Yasuhiro Akai, Miyuki Furuya, Yasuaki Hayashino, Yasunori Sato, Hitoshi Ishii

Research output: Contribution to journalArticle

Abstract

Aims/Introduction: Although patient self-efficacy is known to affect adherence to therapy, no available tool measures self-efficacy of insulin therapy administration while addressing the entire therapeutic process and management. In light of this, we developed the ‘Insulin Therapy Self-efficacy Scale (ITSS).’. Materials and Methods: Development of the ITSS involved three phases: (i) item generation and creation of a questionnaire draft; (ii) testing and correcting the items through interviews with patients; and (iii) a multicenter, single-arm study to validate the questionnaire. Results: A factor analysis and Cronbach's α both confirmed good internal consistency in the patients’ confidence regarding the following four factors: the insulin injection procedure, insulin titration, glycemic control and ability to cope with hypoglycemia. Reproducibility was confirmed using weighted κ statistics and intraclass correlations. Good concurrent validity was confirmed with two other questionnaires. The ITSS score was also found to correlate with several patient characteristics and clinical parameters, as well as with a better adherence to injected insulin therapy 6 months later, suggesting the predictive validity of this scale. Conclusions: The ITSS is a reliable and valid tool for assessing and quantifying patients’ self-efficacy. The ITSS estimation of self-efficacy can predict a patient's glycemic control and future adherence to insulin therapy. These characteristics will ensure the usefulness of the ITSS in ensuring a successful therapeutic process for patients and physicians.

Original languageEnglish
JournalJournal of Diabetes Investigation
DOIs
Publication statusAccepted/In press - 2018 Jan 1

Fingerprint

Self Efficacy
Insulin
Therapeutics
Surveys and Questionnaires
Aptitude
Hypoglycemia
Statistical Factor Analysis
Interviews
Physicians

Keywords

  • Insulin therapy
  • Insulin Therapy Self-efficacy Scale (ITSS)
  • Self-efficacy

ASJC Scopus subject areas

  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism

Cite this

Development of a self-efficacy questionnaire, ‘Insulin Therapy Self-efficacy Scale (ITSS)’, for insulin users in Japanese : The Self-Efficacy-Q study. / Nakaue, Junko; Koizumi, Miyuki; Nakajima, Hiroki; Okada, Sadanori; Mohri, Takako; Akai, Yasuhiro; Furuya, Miyuki; Hayashino, Yasuaki; Sato, Yasunori; Ishii, Hitoshi.

In: Journal of Diabetes Investigation, 01.01.2018.

Research output: Contribution to journalArticle

Nakaue, Junko ; Koizumi, Miyuki ; Nakajima, Hiroki ; Okada, Sadanori ; Mohri, Takako ; Akai, Yasuhiro ; Furuya, Miyuki ; Hayashino, Yasuaki ; Sato, Yasunori ; Ishii, Hitoshi. / Development of a self-efficacy questionnaire, ‘Insulin Therapy Self-efficacy Scale (ITSS)’, for insulin users in Japanese : The Self-Efficacy-Q study. In: Journal of Diabetes Investigation. 2018.
@article{be11463bb68a4b6c914272dbfb8a83b8,
title = "Development of a self-efficacy questionnaire, ‘Insulin Therapy Self-efficacy Scale (ITSS)’, for insulin users in Japanese: The Self-Efficacy-Q study",
abstract = "Aims/Introduction: Although patient self-efficacy is known to affect adherence to therapy, no available tool measures self-efficacy of insulin therapy administration while addressing the entire therapeutic process and management. In light of this, we developed the ‘Insulin Therapy Self-efficacy Scale (ITSS).’. Materials and Methods: Development of the ITSS involved three phases: (i) item generation and creation of a questionnaire draft; (ii) testing and correcting the items through interviews with patients; and (iii) a multicenter, single-arm study to validate the questionnaire. Results: A factor analysis and Cronbach's α both confirmed good internal consistency in the patients’ confidence regarding the following four factors: the insulin injection procedure, insulin titration, glycemic control and ability to cope with hypoglycemia. Reproducibility was confirmed using weighted κ statistics and intraclass correlations. Good concurrent validity was confirmed with two other questionnaires. The ITSS score was also found to correlate with several patient characteristics and clinical parameters, as well as with a better adherence to injected insulin therapy 6 months later, suggesting the predictive validity of this scale. Conclusions: The ITSS is a reliable and valid tool for assessing and quantifying patients’ self-efficacy. The ITSS estimation of self-efficacy can predict a patient's glycemic control and future adherence to insulin therapy. These characteristics will ensure the usefulness of the ITSS in ensuring a successful therapeutic process for patients and physicians.",
keywords = "Insulin therapy, Insulin Therapy Self-efficacy Scale (ITSS), Self-efficacy",
author = "Junko Nakaue and Miyuki Koizumi and Hiroki Nakajima and Sadanori Okada and Takako Mohri and Yasuhiro Akai and Miyuki Furuya and Yasuaki Hayashino and Yasunori Sato and Hitoshi Ishii",
year = "2018",
month = "1",
day = "1",
doi = "10.1111/jdi.12914",
language = "English",
journal = "Journal of Diabetes Investigation",
issn = "2040-1116",
publisher = "Blackwell Publishing Asia Pty Ltd",

}

TY - JOUR

T1 - Development of a self-efficacy questionnaire, ‘Insulin Therapy Self-efficacy Scale (ITSS)’, for insulin users in Japanese

T2 - The Self-Efficacy-Q study

AU - Nakaue, Junko

AU - Koizumi, Miyuki

AU - Nakajima, Hiroki

AU - Okada, Sadanori

AU - Mohri, Takako

AU - Akai, Yasuhiro

AU - Furuya, Miyuki

AU - Hayashino, Yasuaki

AU - Sato, Yasunori

AU - Ishii, Hitoshi

PY - 2018/1/1

Y1 - 2018/1/1

N2 - Aims/Introduction: Although patient self-efficacy is known to affect adherence to therapy, no available tool measures self-efficacy of insulin therapy administration while addressing the entire therapeutic process and management. In light of this, we developed the ‘Insulin Therapy Self-efficacy Scale (ITSS).’. Materials and Methods: Development of the ITSS involved three phases: (i) item generation and creation of a questionnaire draft; (ii) testing and correcting the items through interviews with patients; and (iii) a multicenter, single-arm study to validate the questionnaire. Results: A factor analysis and Cronbach's α both confirmed good internal consistency in the patients’ confidence regarding the following four factors: the insulin injection procedure, insulin titration, glycemic control and ability to cope with hypoglycemia. Reproducibility was confirmed using weighted κ statistics and intraclass correlations. Good concurrent validity was confirmed with two other questionnaires. The ITSS score was also found to correlate with several patient characteristics and clinical parameters, as well as with a better adherence to injected insulin therapy 6 months later, suggesting the predictive validity of this scale. Conclusions: The ITSS is a reliable and valid tool for assessing and quantifying patients’ self-efficacy. The ITSS estimation of self-efficacy can predict a patient's glycemic control and future adherence to insulin therapy. These characteristics will ensure the usefulness of the ITSS in ensuring a successful therapeutic process for patients and physicians.

AB - Aims/Introduction: Although patient self-efficacy is known to affect adherence to therapy, no available tool measures self-efficacy of insulin therapy administration while addressing the entire therapeutic process and management. In light of this, we developed the ‘Insulin Therapy Self-efficacy Scale (ITSS).’. Materials and Methods: Development of the ITSS involved three phases: (i) item generation and creation of a questionnaire draft; (ii) testing and correcting the items through interviews with patients; and (iii) a multicenter, single-arm study to validate the questionnaire. Results: A factor analysis and Cronbach's α both confirmed good internal consistency in the patients’ confidence regarding the following four factors: the insulin injection procedure, insulin titration, glycemic control and ability to cope with hypoglycemia. Reproducibility was confirmed using weighted κ statistics and intraclass correlations. Good concurrent validity was confirmed with two other questionnaires. The ITSS score was also found to correlate with several patient characteristics and clinical parameters, as well as with a better adherence to injected insulin therapy 6 months later, suggesting the predictive validity of this scale. Conclusions: The ITSS is a reliable and valid tool for assessing and quantifying patients’ self-efficacy. The ITSS estimation of self-efficacy can predict a patient's glycemic control and future adherence to insulin therapy. These characteristics will ensure the usefulness of the ITSS in ensuring a successful therapeutic process for patients and physicians.

KW - Insulin therapy

KW - Insulin Therapy Self-efficacy Scale (ITSS)

KW - Self-efficacy

UR - http://www.scopus.com/inward/record.url?scp=85053729084&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85053729084&partnerID=8YFLogxK

U2 - 10.1111/jdi.12914

DO - 10.1111/jdi.12914

M3 - Article

C2 - 30136385

AN - SCOPUS:85053729084

JO - Journal of Diabetes Investigation

JF - Journal of Diabetes Investigation

SN - 2040-1116

ER -